Established criteria for disease controlling drugs in ankylosing spondylitis

被引:5
作者
Gladman, DD [1 ]
机构
[1] Toronto Western Hosp, Ctr Prognosis Studies, Toronto, ON M5T 2S8, Canada
关键词
D O I
10.1136/ard.62.9.793
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:793 / 794
页数:2
相关论文
共 20 条
[1]   Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial [J].
Braun, J ;
Brandt, J ;
Listing, J ;
Zink, A ;
Alten, R ;
Golder, W ;
Gromica-Ihle, E ;
Kellner, H ;
Krause, A ;
Schneider, M ;
Sörensen, H ;
Zeidler, H ;
Thriene, W ;
Sieper, J .
LANCET, 2002, 359 (9313) :1187-1193
[2]   International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis [J].
Braun, J ;
Pham, T ;
Sieper, J ;
Davis, J ;
van der Linden, S ;
Dougados, M ;
van der Heijde, D .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (09) :817-824
[3]   Biologic therapies in the spondyloarthritis: new opportunities, new challenges [J].
Braun, J ;
Brandt, J ;
Listing, J ;
Rudwaleit, M ;
Sieper, J .
CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (04) :394-407
[4]  
CARRETT S, 1993, ARTHRITIS RHEUM, V26, P186
[5]   Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis - A Department of Veterans Affairs cooperative study [J].
Clegg, DO ;
Reda, DJ ;
Weisman, MH ;
Blackburn, WD ;
Cush, JJ ;
Cannon, GW ;
Mahowald, ML ;
Schumacher, HR ;
Taylor, T ;
BudimanMak, E ;
Cohen, MR ;
Vasey, FB ;
Luggen, ME ;
Mejias, E ;
Silverman, SL ;
Makkena, R ;
Alepa, FP ;
Buxbaum, J ;
Haakenson, CM ;
Ward, RH ;
Manaster, BJ ;
Anderson, RJ ;
Ward, JR ;
Henderson, WG .
ARTHRITIS AND RHEUMATISM, 1996, 39 (12) :2004-2012
[6]  
COHEN MD, 1983, ARTHRITIS RHEUM, V26, P186
[7]  
DAGFINRUD H, 2001, COCHRANE DB SYST REV, V4
[8]  
Davis JC, 2003, ANN RHEUM DIS, V62, P65
[9]  
FERRAZ MB, 1990, J RHEUMATOL, V17, P1482
[10]   Clinical aspects of the spondyloarthropathies [J].
Gladman, DD .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1998, 316 (04) :234-238